Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells. (Q40410062)
Jump to navigation
Jump to search
scientific article published on September 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells. |
scientific article published on September 2005 |
Statements
Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells (English)
Takeshi Kitazaki
Mikio Oka
Yoichi Nakamura
Junji Tsurutani
Seiji Doi
Masa Yasunaga
Masaaki Takemura
1 September 2005